In this edition of UCSF Heart and Vascular Center News, we profile new technologies offered at UCSF for the treatment of cardiovascular diseases. Whether it be coronary artery stenting, endovascular graft placement for complex aortic diseases, computerized radiofrequency ablation for heart rhythm disorders or placement of circulatory assist devices for advanced heart failure, this is a very exciting time at UCSF in the evolution of treatment strategies for heart disease.
Watching our faculty develop these technologies is nothing short of spectacular, and reminds me of watching the first moon landing on black and white television. At that time, who would have thought that it could be done?
Cardiovascular disease has never been better understood, but we still have a long way to go. With greater understanding of the molecular underpinnings of heart disease — such as those being defined by the distinguished UCSF team of John Kane, M.D., Ph.D, and Mary Malloy, M.D. — the treatment possibilities seem endless. The Heart and Vascular Center here at UCSF will likely play a pivotal role in enabling patients to receive — and referring physicians and physicians in training to deliver — these new treatment options.
SCOT MERRICK, M.D.
DIRECTOR OF CARDIOTHORACIC SURGERY
UCSF HEART AND VASCULAR CENTER
UCSF Medical Center Among Top 10 Best Hospitals in Nation
For the seventh consecutive year, UCSF Medical Center ranks among the nation's top 10 premier hospitals, according to the 2007 survey by U.S. News & World Report. This year the survey ranked the medical center No. 7.